W
ASHINGTON — On the surface, pharma’s latest ad and messaging campaign warns of a looming “cliff” for Medicare beneficiaries, suggesting that, unless Congress takes action, seniors’ out-of-pocket costs will soar.
But, in a subtle mixing of messages, the ads also call for Congress to reduce the amount drug makers pay to cover drug costs for seniors in Medicare’s so-called donut hole.
Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
